citalopram has been researched along with mirtazapine in 114 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (4.39) | 18.2507 |
| 2000's | 41 (35.96) | 29.6817 |
| 2010's | 57 (50.00) | 24.3611 |
| 2020's | 11 (9.65) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Klysner, R; Pedersen, L | 1 |
| Hesselink, JK; Panagides, J; Pinder, R; Sambunaris, A; Stahl, SM | 1 |
| Thompson, C | 1 |
| Nutt, DJ | 1 |
| Agren, H; Behnke, K; Helsdingen, JT; Leinonen, E; Skarstein, J | 1 |
| Adhumeau-Auclair, A; Cussac, D; Dekeyne, A; Gobert, A; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Nicolas, JP; Rivet, JM | 1 |
| Gorman, JM; Nierenberg, AA; Stahl, SM | 1 |
| Dekeyne, A; Iob, L; Millan, MJ | 1 |
| Kremer, C; Quitkin, FM; Taylor, BP | 1 |
| Crijns, HJ; Honig, A; Lambert, FP; Ormel, J; Schene, AH; van den Brink, RH; van Melle, JP | 1 |
| Elger, CE; Falkai, P; Kühn, KU; Maier, W; Quednow, BB; Thiel, M | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Bateman, DN; Dhaun, N; Good, AM; Kelly, CA; Laing, WJ; Strachan, FE | 1 |
| Bruscoli, M; Pallanti, S; Quercioli, L | 1 |
| Blackburn-Munro, G; Bomholt, SF; Mikkelsen, JD | 1 |
| Bothmer, J; Langer, S; Ramaekers, JG; Wingen, M | 1 |
| Benazzi, F | 1 |
| Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C | 1 |
| Buecking, A; Khazaal, Y; Vandeleur, CL; Zullino, DF | 1 |
| Biersack, HJ; Broich, K; Clusmann, H; Freymann, N; Joe, A; Maier, W; Reinhardt, M; Schramm, J; Zobel, A | 1 |
| Lambert, WE; Maudens, KE; Van Peteghem, CH; Wille, SM | 1 |
| Al-Adwani, A | 1 |
| Lakatos, L; Rihmer, Z | 1 |
| Albertazzi, P | 1 |
| Amann, B; Hegerl, U; Juckel, G; Mergl, R; Mulert, C; Padberg, F; Pogarell, O; Sterr, A | 1 |
| Alpert, JE; Biggs, M; Fava, M; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Biondi, M; Cairoli, F; Costantini, A; Ferrarese, G; Pasquini, M; Picardi, A; Sternberg, C | 1 |
| Steinmann, C | 1 |
| Akcay, A; Bavbek, N; Kargili, A; Kaya, A | 1 |
| Langer, S; Ramaekers, JG; Wingen, M | 1 |
| Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J | 1 |
| Jagsch, C; Marksteiner, J; Seiringer, E; Windhager, E | 1 |
| de Jonge, P; Honig, A; Kuyper, AM; Ormel, J; Schene, AH; Schins, A; Tulner, D; van Melle, JP | 1 |
| Gallwitz, T; Kirch, MH; Messer, T; Rottach, KG; Schaner, BM; Teufel, LM; Zivotofsky, AZ | 1 |
| Gourion, D | 1 |
| Kálmán, J | 1 |
| Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR | 1 |
| Nakayama, K | 1 |
| Jachymova, M; Jirak, R; Tvrzicka, E; Vecka, M; Zak, A; Zeman, M | 1 |
| Kiss, A; Mischo, M; Nigg, C | 1 |
| Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P | 1 |
| Agius, M; Gardner, J; Liu, K; Zaman, R | 3 |
| Deshpande, A; Ing, A; Rizo, C; Seeman, N | 1 |
| Navarro, V | 1 |
| Bateman, DN; Graham, A; Gray, J; Howell, C; Waring, WS; Wilson, AD | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Di Corcia, D; Gerace, E; Salomone, A; Vincenti, M | 1 |
| Davis, LL; Fava, M; Friedman, ES; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Fava, M; Kallenberg, G; Lebowitz, B; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Abuissa, H; Airey, K; Alla, V; Deshmukh, A; Ulveling, K | 1 |
| Balasubramani, GK; Davis, LL; Fava, M; Gaynes, BN; Howland, RH; Pilkinton, P; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Lenze, EJ | 1 |
| Fava, M; Haley, CL; Kurian, BT; Morris, DW; Nierenberg, AA; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Balasubramani, GK; Kurian, B; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR; Zisook, S | 1 |
| Conradi, HJ; de Jonge, P; Ormel, J; van Melle, JP; Zuidersma, M | 1 |
| Eifler, S; Schirmbeck, F; Waltereit, R; Zink, M | 1 |
| Bartsch, S; Bauer, K; Himmerich, H; Kirkby, KC; Mergl, R; Munzer, A; Petersein, C; Sack, U; Schönherr, J | 1 |
| Bernard, SA; Hamer, RM; Mayer, DK; Nelson, KM; Park, EM; Raddin, RS; Rosenstein, DL | 1 |
| Carmody, T; Kurian, KR; Lesser, I; Morris, D; Myers, A; Rush, AJ; Toups, M; Trivedi, MH; Warden, D; Zisook, S | 1 |
| Ansermot, N; Eap, CB; Hodel, PF | 1 |
| Callado, LF; Díez-Alarcia, R; González-Maeso, J; Meana, JJ; Miranda-Azpiazu, P; Morentin, B; Muguruza, C | 1 |
| Luther, JF; Rush, AJ; Sung, SC; Trivedi, MH; Wisniewski, SR | 1 |
| Goyal, P; Singh, P; Tomar, LR; Tripathi, P | 1 |
| Hegerl, U; Kratzsch, J; Nowak, C; Sander, C; Schmidt, FM; Schönknecht, P | 1 |
| Feld, JJ; Shah, H; Sheehan, K; Sockalingam, S | 1 |
| Chang, HS; Ham, BJ; Lee, HY; Lee, MS; Won, E | 1 |
| Avasthi, A; Chee, KY; Chiu, HF; Chong, MY; Grover, S; He, YL; Kanba, S; Kuga, H; Lee, MS; Sartorius, N; Shen, WW; Shinfuku, N; Si, TM; Sim, K; Tan, CH; Tanra, AJ; Tripathi, A; Udormatn, P; Xiang, YT; Yang, SY | 1 |
| Kamińska, K; Rogóż, Z | 1 |
| Andersen, SE; Gislasson, G; Hansen, AH; Holm, EA; Leth-Møller, KB; Torp-Pedersen, C; Torstensson, M; Ødum, L | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Li, Y; Lu, X; Tao, C; Yan, W | 1 |
| Brzezinski, M; Cason, B; Gregersen, M; Kukreja, J; Nouri, KF; Schuch, LG; Wozniak, C; Yip, A | 1 |
| Chekroud, AM; Gueorguieva, R; Krumholz, HM; Krystal, JH; McCarthy, G; Trivedi, MH | 1 |
| Bonse, A; Hempel, G; Lingg, R; Oberfeld, S; Telger, K; Weber, J | 1 |
| Kamińska, K; Pańczyszyn-Trzewik, P; Rogóż, Z; Sowa-Kućma, M | 1 |
| Gadad, BS; Greer, TL; Jha, MK; Mayes, TL; Minhajuddin, A; Trivedi, MH | 1 |
| Johansen, SS; Linnet, K; Nedahl, M | 1 |
| Dronamraju, N; Greer, TL; Jha, MK; Minhajuddin, A; Trivedi, MH; Wakhlu, S | 1 |
| Bahar, MA; Bos, JHJ; Hak, E; Wang, Y; Wilffert, B | 1 |
| Lorenc-Koci, E; Rogóż, Z; Wąsik, A | 1 |
| Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
| Górska, A; Gołembiowska, K; Kamińska, K; Noworyta-Sokołowska, K; Rogóż, Z; Wojtas, A | 1 |
| Carmody, TJ; De La Garza, N; Grannemann, BD; Killian, MO; Rush, AJ; Trivedi, MH | 1 |
| Cipriani, A; Furukawa, TA; Ikeda, K; Imai, H; Maruo, K; Noma, H; Shinohara, K; Tanaka, S; Yamawaki, S | 1 |
| Jha, MK; Minhajuddin, A; Rush, AJ; South, C; Trivedi, MH | 1 |
| Bacon, F; Clarke, CS; Donkor, Y; Duffy, L; Freemantle, N; Gilbody, S; Hunter, R; Kendrick, T; Kessler, D; King, M; Lanham, P; Lewis, G; Mangin, D; Marston, L; Moore, M; Nazareth, I; Wiles, N | 1 |
| Balcı, N; Demir, Y; Gürbüz, M; Küfrevioğlu, Öİ; Özaslan, MS | 1 |
| Cen, M; Dai, N; Du, L; Luo, L; Shen, J | 1 |
| Andersen, M; Bahmanyar, S; Brandt, L; Linder, M; Mavros, P; Myers, D; Pazzagli, L | 1 |
| Uvais, NA | 1 |
| Cao, L; Chen, J; Fang, M; Fang, Y; Huang, J; Peng, D; Su, Y; Wang, F; Wang, Y; Wang, Z; Wu, Z; Yang, L; Yao, Z; Zhu, Y | 1 |
| Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V | 1 |
| Cao, L; Chen, Y; Fang, Y; Hong, W; Huang, H; Huang, Q; Kong, S; Lyu, D; Peng, D; Qian, N; Wang, F; Wei, Z; Wu, C; Wu, Z; Yang, W; Zhang, M; Zhao, J | 1 |
| Barber, D; Barnett, TA; Bartlett, G; Munro, K; Puzhko, S; Renoux, C; Schuster, T | 1 |
| Kalisch Ellett, LM; Kassie, GM; Nguyen, TA; Pratt, NL; Roughead, EE | 1 |
| Barcella, CA; Eroglu, TE; Folke, F; Gerds, TA; Gislason, GH; Kessing, LV; Kragholm, K; Mohr, GH; Polcwiartek, C; Tan, HL; Torp-Pedersen, C; Wissenberg, M; Zylyftari, N | 1 |
| Chen, J; Guo, R; Li, C; Li, Y; Liu, Y; Ma, Y; Wei, S; Xu, D | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
| Christensen, KS; Gasse, C; Ishtiak-Ahmed, K | 1 |
18 review(s) available for citalopram and mirtazapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Development of new antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Drug Approval; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Receptors, Adrenergic; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Mirtazapine versus selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents, Tricyclic; Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Care of depressed patients with anxiety symptoms.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Citalopram; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Evidence of early onset of antidepressant effect in randomized controlled trials.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Mianserin; Mirtazapine; Personality Inventory; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
[1+1 or 2x1? Another form of dual antidepressive mechanism of action].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Clinical Trials as Topic; Cyclohexanols; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride | 2005 |
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride | 2006 |
[Suspected depression].
Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depression; Diagnosis, Differential; Female; Humans; Male; Mianserin; Mirtazapine; Neurology; Psychiatry; Referral and Consultation; Suicide; Time Factors | 2006 |
[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].
Topics: Affect; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Mianserin; Mirtazapine; Patient Satisfaction; Personality Inventory; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Suicide Prevention; Thiophenes; Time Factors; Treatment Refusal; Venlafaxine Hydrochloride | 2008 |
[Genomical and metabolomical abnormalities in Alzheimer disease and in experimental models].
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antidepressive Agents; Apolipoprotein E4; Benzodiazepines; Citalopram; Cyclohexanols; Disease Models, Animal; Gene Expression Regulation; Humans; Hungary; Mianserin; Mirtazapine; Oxidative Stress; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
[Mechanism of action of new generation antidepressants under development in Japan: focusing on dopamine neurotransmission].
Topics: Antidepressive Agents; Citalopram; Dopamine; Duloxetine Hydrochloride; Humans; Japan; Mianserin; Mirtazapine; Synaptic Transmission; Thiophenes | 2009 |
[Depression].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depression; Diagnosis, Differential; Female; HIV Infections; Humans; Hypericum; Mianserin; Middle Aged; Mirtazapine; Phytotherapy; Psychotherapy; Recurrence; Risk Factors; Selective Serotonin Reuptake Inhibitors; Socioeconomic Factors | 2010 |
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2010 |
Improving medication compliance in patients with depression: Use of orodispersible tablets.
Topics: Administration, Oral; Antidepressive Agents; Citalopram; Deglutition Disorders; Depressive Disorder, Major; Dosage Forms; Humans; Medication Adherence; Mianserin; Mirtazapine | 2010 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Japan; Male; Middle Aged; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2021 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
22 trial(s) available for citalopram and mirtazapine
| Article | Year |
|---|---|
Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Dropouts; Psychiatric Status Rating Scales | 1999 |
Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; Mianserin; Mirtazapine; Myocardial Infarction; Prognosis; Quality of Life | 2002 |
Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants.
Topics: Adult; Aged; Analysis of Variance; Anticonvulsants; Antidepressive Agents; Chi-Square Distribution; Citalopram; Demography; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Interactions; Electroencephalography; Epilepsy, Temporal Lobe; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Patient Dropouts; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales; Reboxetine; Time Factors | 2003 |
Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
Topics: Adult; Age of Onset; Antidepressive Agents, Tricyclic; Citalopram; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Mirtazapine; Nausea; Obsessive-Compulsive Disorder; Pilot Projects; Prevalence; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Outcome; Weight Gain | 2004 |
Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.
Topics: Adult; Affect; Antidepressive Agents, Tricyclic; Automobile Driving; Circadian Rhythm; Citalopram; Computer Simulation; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Humans; Male; Mianserin; Mirtazapine; Neuropsychological Tests; Placebos; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders | 2005 |
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Cross-Over Studies; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Mianserin; Middle Aged; Mirtazapine; Nortriptyline; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome | 2006 |
Verbal memory performance during subchronic challenge with a selective serotonergic and a mixed action antidepressant.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Citalopram; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Memory; Mianserin; Mirtazapine; Neuropsychological Tests; Photic Stimulation; Time Factors; Verbal Learning | 2006 |
Motor cortex excitability after vagus nerve stimulation in major depression.
Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid | 2007 |
Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events.
Topics: Antidepressive Agents; Cardiovascular Diseases; Cause of Death; Citalopram; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Myocardial Infarction; Placebos; Prognosis; Proportional Hazards Models; Prospective Studies; Psychiatric Status Rating Scales; Risk Factors; Treatment Failure | 2007 |
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicide; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Regression Analysis; Risk Factors; Self Report; Single-Blind Method; Suicidal Ideation; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
Topics: Adolescent; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Substance-Related Disorders; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prognosis; Prospective Studies; Psychometrics; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Bupropion; Child Abuse; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Mianserin; Middle Aged; Mirtazapine; Placebos; Psychiatric Status Rating Scales; Quality of Life; Recurrence; Self Report; Severity of Illness Index; Single-Blind Method; Suicidal Ideation; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: a randomized controlled trial.
Topics: Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Myocardial Infarction; Patient Readmission; Personality Inventory; Psychometrics; Psychotherapy; Risk; Secondary Prevention; Survival Rate | 2013 |
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
Topics: Adult; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Placebos; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Outpatients; Predictive Value of Tests; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2015 |
Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; Body Mass Index; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Overweight; Patient Selection; Treatment Outcome; Venlafaxine Hydrochloride | 2018 |
The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluation.
Topics: Adult; Aged; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Mirtazapine; Outcome Assessment, Health Care; Psychometrics; Risk Assessment; Self Report; Single-Blind Method; Suicidal Ideation; Venlafaxine Hydrochloride | 2019 |
A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRes
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Depression; Double-Blind Method; Fluoxetine; Humans; Middle Aged; Mirtazapine; Outcome Assessment, Health Care; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sample Size; Sertraline | 2019 |
Predictors and moderators of quality of life in patients with major depressive disorder: An AGTs-MDD study report.
Topics: Citalopram; Depressive Disorder, Major; Female; Humans; Male; Mirtazapine; Quality of Life; Suicidal Ideation | 2021 |
Difference in the regulation of biological rhythm symptoms of Major depressive disorder between escitalopram and mirtazapine.
Topics: Circadian Rhythm; Citalopram; Depressive Disorder, Major; Double-Blind Method; Escitalopram; Humans; Mirtazapine; Treatment Outcome | 2022 |
74 other study(ies) available for citalopram and mirtazapine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Antagonism of selective serotonin reuptake inhibitor-induced nausea by mirtazapine.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Selective Serotonin Reuptake Inhibitors | 1997 |
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents, Tricyclic; Cerebral Cortex; Citalopram; Discrimination, Psychological; Dopamine; Electrophysiology; Frontal Lobe; Humans; Limbic System; Male; Mianserin; Mirtazapine; Norepinephrine; Pain; Penile Erection; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sympathetic Nervous System; Synaptic Transmission | 2000 |
Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Citalopram; Discrimination Learning; Male; Mianserin; Mirtazapine; Rats; Rats, Wistar; Reaction Time; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors | 2001 |
Does mirtazapine have a more rapid onset than SSRIs?
Topics: Antidepressive Agents, Tricyclic; Citalopram; Cross-Sectional Studies; Data Interpretation, Statistical; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Patient Dropouts; Placebo Effect; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Comparative toxicity of citalopram and the newer antidepressants after overdose.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Drug Overdose; Female; Humans; Male; Mianserin; Mirtazapine; Piperazines; Poisoning; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 2004 |
[Motivational therapy can fail here. Sleep disorders in depressions].
Topics: Antidepressive Agents, Tricyclic; Arousal; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Mianserin; Mirtazapine; Motivation; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Wakefulness | 2004 |
Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain.
Topics: Acute Disease; Amitriptyline; Analgesics; Animals; Antidepressive Agents; Chronic Disease; Citalopram; Disease Models, Animal; Duloxetine Hydrochloride; Male; Mianserin; Mirtazapine; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Thiophenes | 2005 |
Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Epistaxis; Gastrointestinal Hemorrhage; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride | 2005 |
Mirtazapine in drug-induced excessive sweating.
Topics: Citalopram; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sweating | 2005 |
Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach.
Topics: Adult; Amygdala; Antidepressive Agents, Tricyclic; Brain; Cerebrovascular Circulation; Citalopram; Combined Modality Therapy; Depressive Disorder, Major; Female; Functional Laterality; Gyrus Cinguli; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Oximes; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Thalamus; Tomography, Emission-Computed, Single-Photon; Transcutaneous Electric Nerve Stimulation; Vagus Nerve | 2005 |
Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Desvenlafaxine Succinate; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Microchemistry; Mirtazapine; Piperazines; Reproducibility of Results; Sertraline | 2005 |
Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Topics: Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Hemorrhage; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
Topics: Adult; Amitriptyline; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Electroencephalography; Epilepsy; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Morpholines; Reboxetine; Venlafaxine Hydrochloride | 2006 |
Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Citalopram; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Mass Screening; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Personality Assessment; Personality Inventory; Psychiatry; Referral and Consultation; Sick Role; Treatment Outcome | 2006 |
Recurrent hyponatremia associated with citalopram and mirtazapine.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Depression; Diagnosis, Differential; Electrolytes; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Mianserin; Mirtazapine; Recurrence; Sodium | 2006 |
Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.
Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Female; Humans; Inappropriate ADH Syndrome; Male; Mianserin; Mirtazapine | 2007 |
Restless legs syndrome as side effect of second generation antidepressants.
Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Prospective Studies; Reboxetine; Restless Legs Syndrome; Selective Serotonin Reuptake Inhibitors | 2008 |
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women.
Topics: Adiponectin; Adult; Aged; Antidepressive Agents; Blood Glucose; Body Mass Index; Chi-Square Distribution; Citalopram; Depression; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Humans; Insulin; Insulin Resistance; Leptin; Mianserin; Middle Aged; Mirtazapine; Patient Selection; Pilot Projects; Waist Circumference | 2009 |
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride | 2011 |
Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.
Topics: Antidepressive Agents; Citalopram; Community Mental Health Services; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Medical Audit; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Patient Discharge; Sertraline; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2010 |
Evaluation of a QT nomogram for risk assessment after antidepressant overdose.
Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Drug Overdose; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Mianserin; Mirtazapine; Nomograms; Retrospective Studies; Risk Assessment; Torsades de Pointes; Venlafaxine Hydrochloride | 2010 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
A fatal case of simultaneous ingestion of mirtazapine, escitalopram, and valproic acid.
Topics: Aged; Autopsy; Citalopram; Fatal Outcome; Female; Forensic Toxicology; Humans; Mianserin; Mirtazapine; Suicide; Valproic Acid | 2011 |
Prolonged QTc interval and torsades de pointes induced by citalopram.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depression; Drug Substitution; Electrocardiography; Female; Heart Conduction System; Humans; Mianserin; Mirtazapine; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Time Factors; Torsades de Pointes | 2012 |
Reversal of SSRI-associated urinary retention with mirtazapine augmentation.
Topics: Adrenergic alpha-Antagonists; Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Citalopram; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Urinary Retention | 2012 |
Visual and auditory hallucinations associated with citalopram treatment.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Drug Substitution; Drug Therapy, Combination; Hallucinations; Humans; Male; Mianserin; Mirtazapine; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome; Young Adult | 2013 |
Impact of antidepressants on cytokine production of depressed patients in vitro.
Topics: Adult; Antidepressive Agents; CD40 Antigens; Citalopram; Cytokines; Depression; Female; Humans; Interleukin-17; Interleukin-1beta; Interleukin-2; Interleukin-22; Interleukin-4; Interleukin-6; Interleukins; Male; Mianserin; Middle Aged; Mirtazapine; Muromonab-CD3; Tumor Necrosis Factor-alpha | 2013 |
A pilot study to evaluate symptom-oriented selection of antidepressants in patients with cancer.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Feasibility Studies; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Pilot Projects; Psychiatric Status Rating Scales; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2014 |
Serotonin toxicity after addition of mirtazapine to escitalopram.
Topics: Adult; Antidepressive Agents; Citalopram; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Serotonin Syndrome | 2014 |
Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.
Topics: Amino Acids; Animals; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Down-Regulation; Female; Humans; Ketanserin; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Prefrontal Cortex; Radioligand Assay; Rats, Sprague-Dawley; Reboxetine; Receptor, Serotonin, 5-HT2A; Receptors, Metabotropic Glutamate; RNA, Messenger; Tritium; Xanthenes | 2014 |
An unusual presentation of dose dependent SIADH secondary to mirtazapine therapy.
Topics: Aged; Antidepressive Agents; Citalopram; Depression; Dose-Response Relationship, Drug; Humans; Inappropriate ADH Syndrome; Male; Mianserin; Mirtazapine | 2015 |
Dynamics of melanin-concentrating hormone (MCH) serum levels in major depressive disorder during antidepressant treatment.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Hypothalamic Hormones; Hypothalamus; Male; Melanins; Mianserin; Mirtazapine; Pituitary Hormones; Sex Factors; Treatment Outcome | 2015 |
Psychiatric care during hepatitis C treatment: the changing role of psychiatrists in the era of direct-acting antivirals.
Topics: Antidepressive Agents; Antiviral Agents; Citalopram; Comorbidity; Cooperative Behavior; Delirium; Depressive Disorder; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Forecasting; Hepatitis C, Chronic; Heterocyclic Compounds, 3-Ring; Humans; Interdisciplinary Communication; Interferon alpha-2; Interferon-alpha; Male; Mianserin; Middle Aged; Mirtazapine; Physician's Role; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Simeprevir; Sofosbuvir; Sulfonamides; Uridine Monophosphate | 2015 |
Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Topics: Adult; Antidepressive Agents; Biomarkers, Pharmacological; Case-Control Studies; Citalopram; Corticotropin-Releasing Hormone; Depressive Disorder, Major; Female; Gene-Environment Interaction; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Humans; Hypothalamo-Hypophyseal System; Male; Mianserin; Middle Aged; Mirtazapine; Pituitary-Adrenal System; Polymorphism, Single Nucleotide; Risk Factors | 2015 |
Antidepressant Prescription Pattern in the Presence of Medical Co-morbidity: REAP-AD 2013 Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Tricyclic; Asia; Child; Citalopram; Comorbidity; Depression; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Practice Patterns, Physicians'; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Young Adult | 2015 |
The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats.
Topics: Animals; Antidepressive Agents; Citalopram; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Synergism; Male; Mianserin; Mirtazapine; Rats; Risperidone; Social Behavior | 2015 |
Antidepressants and the risk of hyponatremia: a Danish register-based population study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Denmark; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Incidence; Male; Mianserin; Middle Aged; Mirtazapine; Registries; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sodium; Venlafaxine Hydrochloride | 2016 |
Effect of antidepressants on spatial memory deficit induced by dizocilpine.
Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride | 2016 |
Serotonin Syndrome Following an Uncomplicated Orthopedic Surgery in a Patient With Post-Traumatic Stress Disorder.
Topics: Adult; Citalopram; Diskectomy; Drug-Related Side Effects and Adverse Reactions; Humans; Low Back Pain; Male; Mianserin; Mirtazapine; Orthopedic Procedures; Serotonin Receptor Agonists; Serotonin Syndrome; Stress Disorders, Post-Traumatic; Veterans | 2016 |
Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Bupropion; Citalopram; Cluster Analysis; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Randomized Controlled Trials as Topic; Sleep; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2017 |
Validation of a dried blood spot method for therapeutic drug monitoring of citalopram, mirtazapine and risperidone and its active metabolite 9-hydroxyrisperidone using HPLC-MS.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Citalopram; Dried Blood Spot Testing; Drug Monitoring; Humans; Mianserin; Mirtazapine; Paliperidone Palmitate; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry | 2017 |
Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Drug Interactions; Fluoxetine; Frontal Lobe; Gene Expression Regulation; Hippocampus; Mianserin; Mirtazapine; Rats; Rats, Wistar; Risperidone; RNA, Messenger; Serotonin Antagonists | 2017 |
Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; Bupropion; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Inflammation; Interleukin-17; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Severity of Illness Index; T-Lymphocytes; Venlafaxine Hydrochloride | 2017 |
Reference Brain/Blood Concentrations of Citalopram, Duloxetine, Mirtazapine and Sertraline.
Topics: Antidepressive Agents; Brain; Calibration; Cause of Death; Chromatography, Liquid; Citalopram; Drug Overdose; Duloxetine Hydrochloride; Forensic Toxicology; Humans; Linear Models; Mianserin; Mirtazapine; Reference Standards; Reproducibility of Results; Sertraline; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2018 |
Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly.
Topics: Aged; Aged, 80 and over; Citalopram; Cohort Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Prescriptions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Metoprolol; Middle Aged; Mirtazapine; Netherlands; Paroxetine | 2018 |
Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Drug Therapy, Combination; Hyperkinesis; Male; Memory Disorders; Mianserin; Mice; Mirtazapine; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology | 2018 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex.
Topics: Animals; Antidepressive Agents; Catalepsy; Citalopram; Dopamine; Drug Synergism; Frontal Lobe; Locomotion; Male; Mianserin; Mirtazapine; Rats; Recognition, Psychology; Risperidone; Serotonin | 2018 |
Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Female; Humans; Irritable Mood; Logistic Models; Male; Middle Aged; Mirtazapine; Prognosis; Randomized Controlled Trials as Topic; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
Inhibition effects of some antidepressant drugs on pentose phosphate pathway enzymes.
Topics: Antidepressive Agents; Aripiprazole; Citalopram; Erythrocytes; Glucosephosphate Dehydrogenase; Haloperidol; Humans; Mirtazapine; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase | 2019 |
Benefit of small dose antidepressants for functional dyspepsia: Experience from a tertiary center in eastern China.
Topics: Anthracenes; Antidepressive Agents; China; Citalopram; Drug Combinations; Dyspepsia; Female; Fluoxetine; Flupenthixol; Humans; Male; Middle Aged; Mirtazapine; Postprandial Period; Remission Induction; Retrospective Studies; Treatment Outcome | 2019 |
Methods for constructing treatment episodes and impact on exposure-outcome associations.
Topics: Ambulatory Care; Antidepressive Agents; Citalopram; Dose-Response Relationship, Drug; Hospitalization; Humans; Mirtazapine; Outcome Assessment, Health Care; Registries; Sweden; Time Factors | 2020 |
Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Betacoronavirus; Citalopram; Clonazepam; Coronavirus Infections; COVID-19; Depressive Disorder; Female; Humans; India; Lorazepam; Male; Mirtazapine; Pandemics; Panic Disorder; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Difference in patterns of prescribing antidepressants known for their weight-modulating and cardiovascular side effects for patients with obesity compared to patients with normal weight.
Topics: Adult; Antidepressive Agents; Canada; Citalopram; Female; Humans; Mirtazapine; Obesity | 2021 |
The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study.
Topics: Aged; Antidepressive Agents; Australia; Case-Control Studies; Central Nervous System; Citalopram; Delirium; Fluvoxamine; Humans; Mirtazapine; Nitrazepam; Risk Factors; Sertraline; Venlafaxine Hydrochloride | 2022 |
Risk of out-of-hospital cardiac arrest in antidepressant drug users.
Topics: Antidepressive Agents; Case-Control Studies; Citalopram; Humans; Mirtazapine; Norepinephrine; Out-of-Hospital Cardiac Arrest; Potassium Channels; Selective Serotonin Reuptake Inhibitors | 2022 |
Combined toxicity and toxicity persistence of antidepressants citalopram and mirtazapine to zooplankton Daphnia magna.
Topics: alpha-Amylases; Animals; Antidepressive Agents; Aquatic Organisms; Citalopram; Cytidine Triphosphate; Daphnia; Mirtazapine; Trypsin; Water Pollutants, Chemical; Zooplankton | 2022 |
Do sociodemographic and clinical factors affect the selection of initial antidepressant treatment for depression in older adults? Results from a nationwide descriptive study in Denmark.
Topics: Aged; Antidepressive Agents; Citalopram; Cross-Sectional Studies; Denmark; Depression; Escitalopram; Humans; Mirtazapine; Sertraline | 2023 |